Ligand · W2D
W2D · 2-amino-5-(1,3-benzodioxol-5-ylmethyl)[1,2,4]triazolo[1,5-c]quinazoline-8-sulfonamide
W2D, 2-amino-5-(1,3-benzodioxol-5-ylmethyl)[1,2,4]triazolo[1,5-c]quinazoline-8-sulfonamide (C17 H14 N6 O4 S, 398.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within…
- Component
- W2D
- Formula
- C17 H14 N6 O4 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
W2D in 2 structures; the first of them:
- 4CWQ · Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor · W2D A1224 · binds ASN51, SER52, ALA55, LYS58, ASP93, ILE96, GLY97, MET98 and 9 more
- 4CWQ · Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline inhibitor · W2D A1224 · binds ASN51, SER52, ALA55, LYS58, ASP93, ILE96, GLY97, MET98 and 9 more
Residues it binds most
ASP 2, LEU 2, ALA 2, ASN 2, GLY 2, HIS 2, ILE 2, LYS 2, MET 2, PHE 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.